Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 225-306-3 | CAS number: 4767-03-7
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Genetic toxicity in vitro
Bacterial reverse mutation test
The potential of Bis-MPA (2,2 -dimethylol propionic acid) to cause genetic damage was evaluated in a GLP study conducted according to OECD TG 471 (van Delft, 1998). Salmonella typhimurium strains TA1535, TA1537, TA98 and TA100 were tested both in the presence and absence of metabolic activation. There was no evidence of toxicity or mutagenicity up to concentrations of 5000 µg/plate. Therefore it was concluded that Bis-MPA was not mutagenic under the conditions of the study.
In a second GLP study according to OECD Guideline 471 (RTC, 2015) Bis-MPA was examined for the ability to induce gene mutations in Escherichia coli strain WP2 uvrA. It is concluded that Bis-MPA did not induce reverse mutation in Escherichia coli in the absence or presence of S9 metabolism, under the reported experimental conditions.
Mammalian cell gene mutation test
A GLP gene mutation study was performed with Bis-MPA (2,2 -dimethylol propionic acid), according to OECD TG 476 (van Delft, 1998). The potential of the test substance to induce mutations at the TK-locus of L5178Y cells was determined, both in the presence and absence of metabolic activation. Bis-MPA was not found to be cytotoxic or genotoxic, either in the presence or absence of metabolic activation, tested up to a concentration of 10 mM.
Mammalian chromosome aberration test
A GLP chromosome aberration study was performed with Bis-MPA (2,2 -dimethylol propionic acid), according to OECD TG 473 (van Delft, 1998). The study was carried out with Chinese hamster ovary cells, in the presence and absence of metabolic activation, up to a concentration of 1250 µg/ml. Under the conditions of the study, Bis-MPA was found to be non-clastogenic.
Justification for selection of genetic toxicity endpoint
A weight of evidence approach is taken for this endpoint: no key study is identified. Three in vitro studies of genotoxicity are available, all studies report negative results.
Short description of key information:
Bis-MPA (dimethylol propionic acid) was not mutagenic or clastogenic when tested in vitro in a bacterial reverse mutation assay, a mammalian cell gene mutation assay, and a mammalian chromosome aberration test.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Dimethylolpropionic acid was not mutagenic or clastogenic when tested in vitro in a bacterial reverse mutation assay, a mammalian cell gene mutation assay, and a mammalian chromosome aberration test. Classification according to DSD or to Regulation (EC) No 1272/2008 is therefore not required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
